Stay updated on Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T22:42:25.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:45:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-04T22:23:51.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The 403 error block and its associated Home link were deleted. This change suggests the page now presents the actual study details instead of an error screen.
    Difference
    0.5%
    Check dated 2026-09-27T23:16:51.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error (with a simple header and a Home link) instead of rendering the study record content. This indicates the study page is unavailable or restricted, replacing the expected trial details with an access-denied message.
    Difference
    31%
    Check dated 2026-09-20T22:43:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, signaling a new release of the platform. This update pertains to the site's underlying software rather than changes to the study content on the page.
    Difference
    0.0%
    Check dated 2026-08-30T22:01:22.000Z thumbnail image

Stay in the know with updates to Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Niraparib Combo With TSR-042 in Ovarian Cancer Clinical Trial page.